Geron | GERN - Pre Tax Profit

Stock Price
1.52
Daily Change
0.06 4.11%
Monthly
10.95%
Yearly
-48.12%
Q1 Forecast
1.33

Geron reported $-18.43M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Amgen USD 3.92B 2.35B Sep/2025
Bio Techne USD 84.99M 107.85M Sep/2025
Cassava Sciences USD -10.81M 33.41M Sep/2025
Cytokinetics USD -306.18M 171.81M Sep/2025
Exelixis USD 252.41M 22M Sep/2025
Genmab DKK 482M 59M Sep/2025
Geron USD -18.43M 2.05M Sep/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Incyte USD 482.31M 75.7M Sep/2025
MacroGenics USD 16.82M 52.97M Sep/2025
Novartis USD 4.2B 335M Sep/2025